調査レポート | • レポートコード：QYR2104Z1514 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、調剤薬局のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（PIA、PAA、CUPM、PDA、SAPM）、用途別市場規模（消費者18歳以下、消費者19歳～44歳、消費者45歳～64歳、消費者65歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・調剤薬局の市場動向 ・企業の競争状況、市場シェア ・調剤薬局の種類別市場規模（PIA、PAA、CUPM、PDA、SAPM） ・調剤薬局の用途別市場規模（消費者18歳以下、消費者19歳～44歳、消費者45歳～64歳、消費者65歳以上） ・調剤薬局の北米市場規模2016-2027（アメリカ、カナダ） ・調剤薬局のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・調剤薬局のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・調剤薬局の中南米市場規模2016-2027（メキシコ、ブラジル） ・調剤薬局の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（PharMEDium Services、B. Braun Group、Fagron、Wedgewood Pharmacy、New Compounding Pharma、Medisca、Fresenius Kabi、Advanced Pharma、AIN GROUP、Nihon Chouzai、Sogo Medical、Dougherty’s Pharmacy、Apollo Pharmacy、Downing Labs、Qol Holdings、Olympia Pharmacy、PUMCH、Triangle Compounding Pharmacy、Peking University First Hospital、Affiliated Hospital of Guangdong Public Institution of Medicine、Lorraine's Pharmacy、PLAGH、Institutional Pharmacy Solutions、Ruijin Hospital） ・結論 |
Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
Market Analysis and Insights: Global Compounding Pharmacy Market
The global Compounding Pharmacy market size is projected to reach US$ 13500 million by 2026, from US$ 11180 million in 2019, at a CAGR of 2.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Compounding Pharmacy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Compounding Pharmacy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Compounding Pharmacy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Compounding Pharmacy market.
Global Compounding Pharmacy Scope and Market Size
Compounding Pharmacy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Compounding Pharmacy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PIA
PAA
CUPM
PDA
SAPM
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Wedgewood Pharmacy
New Compounding Pharma
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine’s Pharmacy
PLAGH
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compounding Pharmacy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PIA
1.2.3 PAA
1.2.4 CUPM
1.2.5 PDA
1.2.6 SAPM
1.3 Market by Application
1.3.1 Global Compounding Pharmacy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Consumers Aged 18 and Younger
1.3.3 Consumers Aged 19 to 44
1.3.4 Consumers Aged 45 to 64
1.3.5 Consumers Aged 65 and Older
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Compounding Pharmacy Market Perspective (2016-2027)
2.2 Compounding Pharmacy Growth Trends by Regions
2.2.1 Compounding Pharmacy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Compounding Pharmacy Historic Market Share by Regions (2016-2021)
2.2.3 Compounding Pharmacy Forecasted Market Size by Regions (2022-2027)
2.3 Compounding Pharmacy Industry Dynamic
2.3.1 Compounding Pharmacy Market Trends
2.3.2 Compounding Pharmacy Market Drivers
2.3.3 Compounding Pharmacy Market Challenges
2.3.4 Compounding Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compounding Pharmacy Players by Revenue
3.1.1 Global Top Compounding Pharmacy Players by Revenue (2016-2021)
3.1.2 Global Compounding Pharmacy Revenue Market Share by Players (2016-2021)
3.2 Global Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Compounding Pharmacy Revenue
3.4 Global Compounding Pharmacy Market Concentration Ratio
3.4.1 Global Compounding Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compounding Pharmacy Revenue in 2020
3.5 Compounding Pharmacy Key Players Head office and Area Served
3.6 Key Players Compounding Pharmacy Product Solution and Service
3.7 Date of Enter into Compounding Pharmacy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Compounding Pharmacy Breakdown Data by Type
4.1 Global Compounding Pharmacy Historic Market Size by Type (2016-2021)
4.2 Global Compounding Pharmacy Forecasted Market Size by Type (2022-2027)
5 Compounding Pharmacy Breakdown Data by Application
5.1 Global Compounding Pharmacy Historic Market Size by Application (2016-2021)
5.2 Global Compounding Pharmacy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Compounding Pharmacy Market Size (2016-2027)
6.2 North America Compounding Pharmacy Market Size by Type
6.2.1 North America Compounding Pharmacy Market Size by Type (2016-2021)
6.2.2 North America Compounding Pharmacy Market Size by Type (2022-2027)
6.2.3 North America Compounding Pharmacy Market Size by Type (2016-2027)
6.3 North America Compounding Pharmacy Market Size by Application
6.3.1 North America Compounding Pharmacy Market Size by Application (2016-2021)
6.3.2 North America Compounding Pharmacy Market Size by Application (2022-2027)
6.3.3 North America Compounding Pharmacy Market Size by Application (2016-2027)
6.4 North America Compounding Pharmacy Market Size by Country
6.4.1 North America Compounding Pharmacy Market Size by Country (2016-2021)
6.4.2 North America Compounding Pharmacy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Compounding Pharmacy Market Size (2016-2027)
7.2 Europe Compounding Pharmacy Market Size by Type
7.2.1 Europe Compounding Pharmacy Market Size by Type (2016-2021)
7.2.2 Europe Compounding Pharmacy Market Size by Type (2022-2027)
7.2.3 Europe Compounding Pharmacy Market Size by Type (2016-2027)
7.3 Europe Compounding Pharmacy Market Size by Application
7.3.1 Europe Compounding Pharmacy Market Size by Application (2016-2021)
7.3.2 Europe Compounding Pharmacy Market Size by Application (2022-2027)
7.3.3 Europe Compounding Pharmacy Market Size by Application (2016-2027)
7.4 Europe Compounding Pharmacy Market Size by Country
7.4.1 Europe Compounding Pharmacy Market Size by Country (2016-2021)
7.4.2 Europe Compounding Pharmacy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Compounding Pharmacy Market Size (2016-2027)
8.2 Asia-Pacific Compounding Pharmacy Market Size by Type
8.2.1 Asia-Pacific Compounding Pharmacy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Compounding Pharmacy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Compounding Pharmacy Market Size by Type (2016-2027)
8.3 Asia-Pacific Compounding Pharmacy Market Size by Application
8.3.1 Asia-Pacific Compounding Pharmacy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Compounding Pharmacy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Compounding Pharmacy Market Size by Application (2016-2027)
8.4 Asia-Pacific Compounding Pharmacy Market Size by Region
8.4.1 Asia-Pacific Compounding Pharmacy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Compounding Pharmacy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Compounding Pharmacy Market Size (2016-2027)
9.2 Latin America Compounding Pharmacy Market Size by Type
9.2.1 Latin America Compounding Pharmacy Market Size by Type (2016-2021)
9.2.2 Latin America Compounding Pharmacy Market Size by Type (2022-2027)
9.2.3 Latin America Compounding Pharmacy Market Size by Type (2016-2027)
9.3 Latin America Compounding Pharmacy Market Size by Application
9.3.1 Latin America Compounding Pharmacy Market Size by Application (2016-2021)
9.3.2 Latin America Compounding Pharmacy Market Size by Application (2022-2027)
9.3.3 Latin America Compounding Pharmacy Market Size by Application (2016-2027)
9.4 Latin America Compounding Pharmacy Market Size by Country
9.4.1 Latin America Compounding Pharmacy Market Size by Country (2016-2021)
9.4.2 Latin America Compounding Pharmacy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compounding Pharmacy Market Size (2016-2027)
10.2 Middle East & Africa Compounding Pharmacy Market Size by Type
10.2.1 Middle East & Africa Compounding Pharmacy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Compounding Pharmacy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Compounding Pharmacy Market Size by Type (2016-2027)
10.3 Middle East & Africa Compounding Pharmacy Market Size by Application
10.3.1 Middle East & Africa Compounding Pharmacy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Compounding Pharmacy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Compounding Pharmacy Market Size by Application (2016-2027)
10.4 Middle East & Africa Compounding Pharmacy Market Size by Country
10.4.1 Middle East & Africa Compounding Pharmacy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Compounding Pharmacy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 PharMEDium Services
11.1.1 PharMEDium Services Company Details
11.1.2 PharMEDium Services Business Overview
11.1.3 PharMEDium Services Compounding Pharmacy Introduction
11.1.4 PharMEDium Services Revenue in Compounding Pharmacy Business (2016-2021)
11.1.5 PharMEDium Services Recent Development
11.2 B. Braun Group
11.2.1 B. Braun Group Company Details
11.2.2 B. Braun Group Business Overview
11.2.3 B. Braun Group Compounding Pharmacy Introduction
11.2.4 B. Braun Group Revenue in Compounding Pharmacy Business (2016-2021)
11.2.5 B. Braun Group Recent Development
11.3 Fagron
11.3.1 Fagron Company Details
11.3.2 Fagron Business Overview
11.3.3 Fagron Compounding Pharmacy Introduction
11.3.4 Fagron Revenue in Compounding Pharmacy Business (2016-2021)
11.3.5 Fagron Recent Development
11.4 Wedgewood Pharmacy
11.4.1 Wedgewood Pharmacy Company Details
11.4.2 Wedgewood Pharmacy Business Overview
11.4.3 Wedgewood Pharmacy Compounding Pharmacy Introduction
11.4.4 Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.4.5 Wedgewood Pharmacy Recent Development
11.5 New Compounding Pharma
11.5.1 New Compounding Pharma Company Details
11.5.2 New Compounding Pharma Business Overview
11.5.3 New Compounding Pharma Compounding Pharmacy Introduction
11.5.4 New Compounding Pharma Revenue in Compounding Pharmacy Business (2016-2021)
11.5.5 New Compounding Pharma Recent Development
11.6 Medisca
11.6.1 Medisca Company Details
11.6.2 Medisca Business Overview
11.6.3 Medisca Compounding Pharmacy Introduction
11.6.4 Medisca Revenue in Compounding Pharmacy Business (2016-2021)
11.6.5 Medisca Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Compounding Pharmacy Introduction
11.7.4 Fresenius Kabi Revenue in Compounding Pharmacy Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 Advanced Pharma
11.8.1 Advanced Pharma Company Details
11.8.2 Advanced Pharma Business Overview
11.8.3 Advanced Pharma Compounding Pharmacy Introduction
11.8.4 Advanced Pharma Revenue in Compounding Pharmacy Business (2016-2021)
11.8.5 Advanced Pharma Recent Development
11.9 AIN GROUP
11.9.1 AIN GROUP Company Details
11.9.2 AIN GROUP Business Overview
11.9.3 AIN GROUP Compounding Pharmacy Introduction
11.9.4 AIN GROUP Revenue in Compounding Pharmacy Business (2016-2021)
11.9.5 AIN GROUP Recent Development
11.10 Nihon Chouzai
11.10.1 Nihon Chouzai Company Details
11.10.2 Nihon Chouzai Business Overview
11.10.3 Nihon Chouzai Compounding Pharmacy Introduction
11.10.4 Nihon Chouzai Revenue in Compounding Pharmacy Business (2016-2021)
11.10.5 Nihon Chouzai Recent Development
11.11 Sogo Medical
11.11.1 Sogo Medical Company Details
11.11.2 Sogo Medical Business Overview
11.11.3 Sogo Medical Compounding Pharmacy Introduction
11.11.4 Sogo Medical Revenue in Compounding Pharmacy Business (2016-2021)
11.11.5 Sogo Medical Recent Development
11.12 Dougherty’s Pharmacy
11.12.1 Dougherty’s Pharmacy Company Details
11.12.2 Dougherty’s Pharmacy Business Overview
11.12.3 Dougherty’s Pharmacy Compounding Pharmacy Introduction
11.12.4 Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.12.5 Dougherty’s Pharmacy Recent Development
11.13 Apollo Pharmacy
11.13.1 Apollo Pharmacy Company Details
11.13.2 Apollo Pharmacy Business Overview
11.13.3 Apollo Pharmacy Compounding Pharmacy Introduction
11.13.4 Apollo Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.13.5 Apollo Pharmacy Recent Development
11.14 Downing Labs
11.14.1 Downing Labs Company Details
11.14.2 Downing Labs Business Overview
11.14.3 Downing Labs Compounding Pharmacy Introduction
11.14.4 Downing Labs Revenue in Compounding Pharmacy Business (2016-2021)
11.14.5 Downing Labs Recent Development
11.15 Qol Holdings
11.15.1 Qol Holdings Company Details
11.15.2 Qol Holdings Business Overview
11.15.3 Qol Holdings Compounding Pharmacy Introduction
11.15.4 Qol Holdings Revenue in Compounding Pharmacy Business (2016-2021)
11.15.5 Qol Holdings Recent Development
11.16 Olympia Pharmacy
11.16.1 Olympia Pharmacy Company Details
11.16.2 Olympia Pharmacy Business Overview
11.16.3 Olympia Pharmacy Compounding Pharmacy Introduction
11.16.4 Olympia Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.16.5 Olympia Pharmacy Recent Development
11.17 PUMCH
11.17.1 PUMCH Company Details
11.17.2 PUMCH Business Overview
11.17.3 PUMCH Compounding Pharmacy Introduction
11.17.4 PUMCH Revenue in Compounding Pharmacy Business (2016-2021)
11.17.5 PUMCH Recent Development
11.18 Triangle Compounding Pharmacy
11.18.1 Triangle Compounding Pharmacy Company Details
11.18.2 Triangle Compounding Pharmacy Business Overview
11.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Introduction
11.18.4 Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.18.5 Triangle Compounding Pharmacy Recent Development
11.18 Peking University First Hospital
.1 Peking University First Hospital Company Details
.2 Peking University First Hospital Business Overview
.3 Peking University First Hospital Compounding Pharmacy Introduction
.4 Peking University First Hospital Revenue in Compounding Pharmacy Business (2016-2021)
.5 Peking University First Hospital Recent Development
11.20 Affiliated Hospital of Guangdong Public Institution of Medicine
11.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Details
11.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
11.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Introduction
11.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2016-2021)
11.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
11.21 Lorraine’s Pharmacy
11.21.1 Lorraine’s Pharmacy Company Details
11.21.2 Lorraine’s Pharmacy Business Overview
11.21.3 Lorraine’s Pharmacy Compounding Pharmacy Introduction
11.21.4 Lorraine’s Pharmacy Revenue in Compounding Pharmacy Business (2016-2021)
11.21.5 Lorraine’s Pharmacy Recent Development
11.22 PLAGH
11.22.1 PLAGH Company Details
11.22.2 PLAGH Business Overview
11.22.3 PLAGH Compounding Pharmacy Introduction
11.22.4 PLAGH Revenue in Compounding Pharmacy Business (2016-2021)
11.22.5 PLAGH Recent Development
11.23 Institutional Pharmacy Solutions
11.23.1 Institutional Pharmacy Solutions Company Details
11.23.2 Institutional Pharmacy Solutions Business Overview
11.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Introduction
11.23.4 Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2016-2021)
11.23.5 Institutional Pharmacy Solutions Recent Development
11.24 Ruijin Hospital
11.24.1 Ruijin Hospital Company Details
11.24.2 Ruijin Hospital Business Overview
11.24.3 Ruijin Hospital Compounding Pharmacy Introduction
11.24.4 Ruijin Hospital Revenue in Compounding Pharmacy Business (2016-2021)
11.24.5 Ruijin Hospital Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Compounding Pharmacy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PIA
Table 3. Key Players of PAA
Table 4. Key Players of CUPM
Table 5. Key Players of PDA
Table 6. Key Players of SAPM
Table 7. Global Compounding Pharmacy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Compounding Pharmacy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Compounding Pharmacy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Compounding Pharmacy Market Share by Regions (2016-2021)
Table 11. Global Compounding Pharmacy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Compounding Pharmacy Market Share by Regions (2022-2027)
Table 13. Compounding Pharmacy Market Trends
Table 14. Compounding Pharmacy Market Drivers
Table 15. Compounding Pharmacy Market Challenges
Table 16. Compounding Pharmacy Market Restraints
Table 17. Global Compounding Pharmacy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Compounding Pharmacy Market Share by Players (2016-2021)
Table 19. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Compounding Pharmacy as of 2020)
Table 20. Ranking of Global Top Compounding Pharmacy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Compounding Pharmacy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Compounding Pharmacy Product Solution and Service
Table 24. Date of Enter into Compounding Pharmacy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Compounding Pharmacy Revenue Market Share by Type (2016-2021)
Table 28. Global Compounding Pharmacy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Compounding Pharmacy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Compounding Pharmacy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Compounding Pharmacy Revenue Market Share by Application (2016-2021)
Table 32. Global Compounding Pharmacy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Compounding Pharmacy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Compounding Pharmacy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Compounding Pharmacy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Compounding Pharmacy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Compounding Pharmacy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Compounding Pharmacy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Compounding Pharmacy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Compounding Pharmacy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Compounding Pharmacy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Compounding Pharmacy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Compounding Pharmacy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Compounding Pharmacy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Compounding Pharmacy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Compounding Pharmacy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Compounding Pharmacy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Compounding Pharmacy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Compounding Pharmacy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Compounding Pharmacy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Compounding Pharmacy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Compounding Pharmacy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Compounding Pharmacy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Compounding Pharmacy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Compounding Pharmacy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Compounding Pharmacy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Compounding Pharmacy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Compounding Pharmacy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Compounding Pharmacy Market Size by Country (2022-2027) & (US$ Million)
Table 64. PharMEDium Services Company Details
Table 65. PharMEDium Services Business Overview
Table 66. PharMEDium Services Compounding Pharmacy Product
Table 67. PharMEDium Services Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 68. PharMEDium Services Recent Development
Table 69. B. Braun Group Company Details
Table 70. B. Braun Group Business Overview
Table 71. B. Braun Group Compounding Pharmacy Product
Table 72. B. Braun Group Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 73. B. Braun Group Recent Development
Table 74. Fagron Company Details
Table 75. Fagron Business Overview
Table 76. Fagron Compounding Pharmacy Product
Table 77. Fagron Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 78. Fagron Recent Development
Table 79. Wedgewood Pharmacy Company Details
Table 80. Wedgewood Pharmacy Business Overview
Table 81. Wedgewood Pharmacy Compounding Pharmacy Product
Table 82. Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 83. Wedgewood Pharmacy Recent Development
Table 84. New Compounding Pharma Company Details
Table 85. New Compounding Pharma Business Overview
Table 86. New Compounding Pharma Compounding Pharmacy Product
Table 87. New Compounding Pharma Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 88. New Compounding Pharma Recent Development
Table 89. Medisca Company Details
Table 90. Medisca Business Overview
Table 91. Medisca Compounding Pharmacy Product
Table 92. Medisca Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 93. Medisca Recent Development
Table 94. Fresenius Kabi Company Details
Table 95. Fresenius Kabi Business Overview
Table 96. Fresenius Kabi Compounding Pharmacy Product
Table 97. Fresenius Kabi Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 98. Fresenius Kabi Recent Development
Table 99. Advanced Pharma Company Details
Table 100. Advanced Pharma Business Overview
Table 101. Advanced Pharma Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 102. Advanced Pharma Recent Development
Table 103. AIN GROUP Company Details
Table 104. AIN GROUP Business Overview
Table 105. AIN GROUP Compounding Pharmacy Product
Table 106. AIN GROUP Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 107. AIN GROUP Recent Development
Table 108. Nihon Chouzai Company Details
Table 109. Nihon Chouzai Business Overview
Table 110. Nihon Chouzai Compounding Pharmacy Product
Table 111. Nihon Chouzai Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 112. Nihon Chouzai Recent Development
Table 113. Sogo Medical Company Details
Table 114. Sogo Medical Business Overview
Table 115. Sogo Medical Compounding Pharmacy Product
Table 116. Sogo Medical Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 117. Sogo Medical Recent Development
Table 118. Dougherty’s Pharmacy Company Details
Table 119. Dougherty’s Pharmacy Business Overview
Table 120. Dougherty’s Pharmacy Compounding Pharmacy Product
Table 121. Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 122. Dougherty’s Pharmacy Recent Development
Table 123. Apollo Pharmacy Company Details
Table 124. Apollo Pharmacy Business Overview
Table 125. Apollo Pharmacy Compounding Pharmacy Product
Table 126. Apollo Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 127. Apollo Pharmacy Recent Development
Table 128. Downing Labs Company Details
Table 129. Downing Labs Business Overview
Table 130. Downing Labs Compounding Pharmacy Product
Table 131. Downing Labs Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 132. Downing Labs Recent Development
Table 133. Qol Holdings Company Details
Table 134. Qol Holdings Business Overview
Table 135. Qol Holdings Compounding Pharmacy Product
Table 136. Qol Holdings Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 137. Qol Holdings Recent Development
Table 138. Olympia Pharmacy Company Details
Table 139. Olympia Pharmacy Business Overview
Table 140. Olympia Pharmacy Compounding Pharmacy Product
Table 141. Olympia Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 142. Olympia Pharmacy Recent Development
Table 143. PUMCH Company Details
Table 144. PUMCH Business Overview
Table 145. PUMCH Compounding Pharmacy Product
Table 146. PUMCH Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 147. PUMCH Recent Development
Table 148. Triangle Compounding Pharmacy Company Details
Table 149. Triangle Compounding Pharmacy Business Overview
Table 150. Triangle Compounding Pharmacy Compounding Pharmacy Product
Table 151. Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 152. Triangle Compounding Pharmacy Recent Development
Table 153. Peking University First Hospital Company Details
Table 154. Peking University First Hospital Business Overview
Table 155. Peking University First Hospital Compounding Pharmacy Product
Table 156. Peking University First Hospital Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 157. Peking University First Hospital Recent Development
Table 158. Affiliated Hospital of Guangdong Public Institution of Medicine Company Details
Table 159. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
Table 160. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product
Table 161. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 162. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
Table 163. Lorraine's Pharmacy Company Details
Table 164. Lorraine's Pharmacy Business Overview
Table 165. Lorraine's Pharmacy Compounding Pharmacy Product
Table 166. Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 167. Lorraine's Pharmacy Recent Development
Table 168. PLAGH Company Details
Table 169. PLAGH Business Overview
Table 170. PLAGH Compounding Pharmacy Product
Table 171. PLAGH Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 172. PLAGH Recent Development
Table 173. Institutional Pharmacy Solutions Company Details
Table 174. Institutional Pharmacy Solutions Business Overview
Table 175. Institutional Pharmacy Solutions Compounding Pharmacy Product
Table 176. Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 177. Institutional Pharmacy Solutions Recent Development
Table 178. Ruijin Hospital Company Details
Table 179. Ruijin Hospital Business Overview
Table 180. Ruijin Hospital Compounding PharmacyProduct
Table 181. Ruijin Hospital Revenue in Compounding Pharmacy Business (2016-2021) & (US$ Million)
Table 182. Ruijin Hospital Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Compounding Pharmacy Market Share by Type: 2020 VS 2027
Figure 2. PIA Features
Figure 3. PAA Features
Figure 4. CUPM Features
Figure 5. PDA Features
Figure 6. SAPM Features
Figure 7. Global Compounding Pharmacy Market Share by Application: 2020 VS 2027
Figure 8. Consumers Aged 18 and Younger Case Studies
Figure 9. Consumers Aged 19 to 44 Case Studies
Figure 10. Consumers Aged 45 to 64 Case Studies
Figure 11. Consumers Aged 65 and Older Case Studies
Figure 12. Compounding Pharmacy Report Years Considered
Figure 13. Global Compounding Pharmacy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Compounding Pharmacy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Compounding Pharmacy Market Share by Regions: 2020 VS 2027
Figure 16. Global Compounding Pharmacy Market Share by Regions (2022-2027)
Figure 17. Global Compounding Pharmacy Market Share by Players in 2020
Figure 18. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Compounding Pharmacy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Compounding Pharmacy Revenue in 2020
Figure 20. Global Compounding Pharmacy Revenue Market Share by Type (2016-2021)
Figure 21. Global Compounding Pharmacy Revenue Market Share by Type (2022-2027)
Figure 22. North America Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Compounding Pharmacy Market Share by Type (2016-2027)
Figure 24. North America Compounding Pharmacy Market Share by Application (2016-2027)
Figure 25. North America Compounding Pharmacy Market Share by Country (2016-2027)
Figure 26. United States Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Compounding Pharmacy Market Share by Type (2016-2027)
Figure 30. Europe Compounding Pharmacy Market Share by Application (2016-2027)
Figure 31. Europe Compounding Pharmacy Market Share by Country (2016-2027)
Figure 32. Germany Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Compounding Pharmacy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Compounding Pharmacy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Compounding Pharmacy Market Share by Region (2016-2027)
Figure 42. China Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Compounding Pharmacy Market Share by Type (2016-2027)
Figure 50. Latin America Compounding Pharmacy Market Share by Application (2016-2027)
Figure 51. Latin America Compounding Pharmacy Market Share by Country (2016-2027)
Figure 52. Mexico Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Compounding Pharmacy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Compounding Pharmacy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Compounding Pharmacy Market Share by Country (2016-2027)
Figure 58. Turkey Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Compounding Pharmacy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. PharMEDium Services Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 62. B. Braun Group Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 63. Fagron Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 64. Wedgewood Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 65. New Compounding Pharma Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 66. Medisca Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 67. Fresenius Kabi Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 68. Advanced Pharma Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 69. AIN GROUP Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 70. Nihon Chouzai Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 71. Sogo Medical Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 72. Dougherty’s Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 73. Apollo Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 74. Downing Labs Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 75. Qol Holdings Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 76. Olympia Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 77. PUMCH Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 78. Triangle Compounding Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 79. Peking University First Hospital Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 80. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 81. Lorraine's Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 82. PLAGH Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 83. Institutional Pharmacy Solutions Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 84. Ruijin Hospital Revenue Growth Rate in Compounding Pharmacy Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
世界の非滅菌調剤医薬品市場規模・現状・予測（2021年-2027年） Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsteril…- 世界の犬用ブーツ市場 2021：企業別、地域別、種類・用途別 The Dog Boots market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent d…
- 世界のフレーバー動物用医薬品市場規模・現状・予測（2021年-2027年） Flavoring veterinary drugs are common veterinary drugs with flavor. Boehringer-ingelheim has more than 35% market share in the world, followed by Elanco Animal Health with 15% market share. Market Analysis and Insights: Global Flavored Veterinary Medication Market The global Flavored Veterinary Medi…
- 世界の調剤自動化システム市場規模・現状・予測（2021年-2027年） Pharmacy Automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline ph…
- 世界の調剤自動化市場規模・現状・予測（2021年-2027年） Pharmacy Automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline ph…